Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Biomarkers and targeted therapy for cancer stem cells
Yusheng Liu, Hua Wang
Trends in Pharmacological Sciences (2023) Vol. 45, Iss. 1, pp. 56-66
Closed Access | Times Cited: 14

Showing 14 citing articles:

Enhancing cancer therapy: the integration of oncolytic virus therapy with diverse treatments
Yan Zhuo, Zhengbo Zhang, Yanan Chen, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 11
Predicting hepatocellular carcinoma outcomes and immune therapy response with ATP-dependent chromatin remodeling-related genes, highlighting MORF4L1 as a promising target
Chao Xu, Litao Liang, Guoqing Liu, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
Unraveling the underlying mechanisms of cancer stem cells in therapeutic resistance for optimizing treatment strategies
Yunhan Tan, Siyuan Qin, Zhe Zhang, et al.
MedComm – Oncology (2025) Vol. 4, Iss. 1
Open Access
Cancer stem cell analysis and targeting
Mishal Safdar, Z. M. Amin, Muneeb Ullah, et al.
Methods in cell biology (2025)
Closed Access
The hsa-miR-1246 is overexpressed in Spheroids-derived cancer stem cells from tumor cell lines
Ângela Maggio da Fonseca, Yeimy Gonzalez Giraldo, Natalia Vargas Rondón, et al.
(2025)
Closed Access
RBBP4 downregulation increases the sensitivity of A549 and HeLa cells to cisplatin by inhibiting cyclin D1 expression
Zhiyu Zeng, Meiqing Mai, Dandan Wang, et al.
Clinics (2025) Vol. 80, pp. 100637-100637
Open Access
The impact of compression and confinement in tumor growth and progression: emerging concepts in cancer mechanobiology
Allison McKenzie Johnson, Charles Froman-Glover, Akshitkumar M. Mistry, et al.
Frontiers in Materials (2025) Vol. 12
Open Access
Exploring Importance and Regulation of Autophagy in Cancer Stem Cells and Stem Cell-Based Therapies
Md. Ataur Rahman, Ehsanul Hoque Apu, S M Rakib-Uz-Zaman, et al.
Cells (2024) Vol. 13, Iss. 11, pp. 958-958
Open Access | Times Cited: 2
Role of Cancer Side Population Stem Cells in Ovarian Cancer Angiogenesis
Yue Pan, XueFen Yang, Miaojuan Chen, et al.
Medical Principles and Practice (2024) Vol. 33, Iss. 5, pp. 403-413
Open Access | Times Cited: 1
Targeting the GTPase RAN by liposome delivery for tackling cancer stemness-emanated therapeutic resistance
Kaili Wang, Sitong Zhu, Ying Zhang, et al.
Journal of Controlled Release (2024) Vol. 375, pp. 589-600
Closed Access | Times Cited: 1
Characterization of the malignant cells and microenvironment of infantile fibrosarcoma via single-cell RNA sequencing
Yi Li, Qingchi Zhang, Ran Yang, et al.
Translational Pediatrics (2024) Vol. 13, Iss. 4, pp. 596-609
Open Access
Cancer Immunotherapies Targeting Cancer Stem Cells: Concepts, Applications, and Advances
Pooya Farhangnia, Mohammad-Reza Shokri, Mahzad Akbarpour, et al.
Interdisciplinary cancer research (2024)
Closed Access
A Multifunctional Nanodrug Increases the Therapeutic Sensitivity of Lenvatinib to Hepatocellular Carcinoma by Inhibiting the Stemness of Hepatic Cancer Stem Cells
Xieqing Yang, Qiaoyun Zhang, Dongye Li, et al.
Advanced Healthcare Materials (2024)
Closed Access
Targeting cancer stem cells by TPA leads to inhibition of refractory sarcoma and extended overall survival.
Karina Galoian, Daniel Bilbao, Carina Denny, et al.
Deleted Journal (2024) Vol. 32, Iss. 4, pp. 200905-200905
Open Access
Page 1

Scroll to top